Bibliographic Details
| Title: |
Certolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid arthritis: findings of a fifty-two-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. |
| Authors: |
Keystone E (AUTHOR), van der Heijde D (AUTHOR), Mason D Jr. (AUTHOR), Landewé R (AUTHOR), van Vollenhoven R (AUTHOR), Combe B (AUTHOR), Emery P (AUTHOR), Strand V (AUTHOR), Mease P (AUTHOR), Desai C (AUTHOR), Pavelka K (AUTHOR) |
| Source: |
Arthritis & Rheumatism. Nov2008, Vol. 58 Issue 11, p3319-3329. 11p. |
| Database: |
Academic Search Ultimate |
